论文部分内容阅读
一般资料:男4例,女8例。年龄:<15岁6例,15～62岁6例。病种:支气管炎5例,其中哮喘型3例;支气管哮喘6例,其中哮喘持续状态2例;肺炎1例。病程:1年以下5例,5年以上7例。收入本组的病例均有明显呼吸困难,两肺闻及大量哮鸣音。入院后即用普鲁卡因5例,用激素、氨茶碱等无效改用普鲁卡因7例。剂量:儿童3～5毫克/公斤/天,成人200毫克/天,静滴。除2例哮喘持续状态联用激素,氨茶碱、纠正酸中毒、吸氧外,其余10例均单用普鲁卡因。用普鲁卡因前均皮试阴性。
General information: 4 males and 8 females. Age: <15 years in 6 cases, 15 to 62 years in 6 cases. Disease: bronchitis in 5 cases, of which 3 cases of asthma; bronchial asthma in 6 cases, of which 2 cases of asthma persistence; pneumonia in 1 case. Course of disease: 5 cases in less than 1 year, 5 cases in more than 7 cases. Income in this group of patients were significantly dyspnea, both lungs smell a lot of wheeze. After admission, procaine 5 cases, with hormone, aminophylline and other ineffective use of procaine in 7 cases. Dosage: 3 to 5 mg / kg / day for children, 200 mg / day for adults, intravenous infusion. In addition to 2 cases of asthma with hormone, aminophylline, correct acidosis, oxygen, the other 10 cases were procaine alone. Pre-procaine with the average skin test negative.